Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 41.00
Ask: 43.00
Change: 1.50 (3.70%)
Spread: 2.00 (4.878%)
Open: 41.50
High: 42.00
Low: 41.50
Prev. Close: 40.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Palintest launches Molendotech bathing water test

15 May 2018 07:00

RNS Number : 9469N
Frontier IP Group plc
15 May 2018
 

RNS REACH / RNS

AIM: FIPP

15 May 2018

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Portfolio news - Palintest launches Molendotech bathing water test

 

 

Frontier IP, which specialises in commercialising university intellectual property, today announces that Palintest, a subsidiary of FTSE 100 group Halma plc, is launching Siren BW, a water testing kit developed by portfolio company Molendotech, a spin out from the University of Plymouth.

 

It is the first commercial application for Molendotech's novel test able to identify the concentration of faecal bacteria in water. Currently, it can take two days for local authorities and environmental agencies to assess the quality of recreational water because samples must be sent to a laboratory. Palintest's field-ready kit produces a result in less than 30 minutes and is simple enough to be used at the sample point.

 

The kit is initially available in the UK and Ireland, with roll out to continental Europe and the US planned.

 

Further applications are now being developed in collaboration with Palintest to leverage the real-time availability of pathogen risk in water. It has a wide range of potential uses, including potable water and in food and beverage production.

 

Molendotech was incorporated less than a year ago to develop and commercialise the work of Simon Jackson, Professor of Environment and Human Health within the University of Plymouth's Peninsula Schools of Medicine and Dentistry.

 

Frontier IP chief executive officer Neil Crabb said: "We're delighted the agreement with Palintest, announced earlier this year, is bearing fruit so quickly. It has taken less than a year from Molendotech joining our portfolio to the commercial launch of its first product."

 

Director of Molendotech, Professor Simon Jackson, said: "Water quality is a global issue and fundamental to human and public health. Unfortunately, traditional, lab-based methods for testing water quality, particularly for faecal contamination, do not deliver the kind of rapid results required for in-situ investigation and decision-making. With this breakthrough, however, environmental agencies will be able to gain a much clearer understanding of water quality, which could lead to better and more effective management of beaches and other recreational bathing waters, and faster identification of sources of pollution."

 

Open Innovation Product Manager at Palintest Ian Leahy said: "The opportunity to bring our ability to produce rugged, simple-to-use water quality testing kits together with this exciting Molendotech innovation is a perfect example of two organisations collaborating to answer a clear customer need in the markets we already serve. For many years we sought opportunities to deliver simple, real-time microbiological risk screening at the point of use and I'm excited to say we are finally at that point now."

 

 

For more product details, please contact ian.leahy@palintest.com

 

 

ENQUIRIES

 

Frontier IP Group Plc

T: 0131 240 1251

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

andrew.johnson@frontierip.co.uk

Company website: www.frontierip.co.uk

 

M: 07464 546 025

Cenkos Securities plc (Nominated Adviser and Joint Broker)

T: 0131 220 6939

Neil McDonald / Beth McKiernan

 

Peterhouse Corporate Finance Limited (Joint Broker)

T: 020 7469 0935

Lucy Williams

 

Kreab (Financial PR)

T: 020 7074 1800

Robert Speed / Matthew Jervois

NOTES TO EDITORS

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services.

The Group looks to build and grow a portfolio of equity stakes and licence income from by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

Frontier IP and the University of Plymouth:

Frontier IP has forged a strong relationship with the University of Plymouth to commercialise intellectual property. Other collaborations include:

· Fieldwork Robotics: developing advanced soft robotics for harvesting fruit and vegetables. The technology has attracted strong industry interest.

· The Vaccine Group: work includes creating novel vaccines to prevent viruses from jumping the species barrier from animals to humans

· Pulsiv Solar: US and European patents granted on its novel technology to improve the energy efficiency of photovoltaic cells and power conversion

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGIGDUUXBBGIS
Date   Source Headline
23rd Mar 20173:27 pmRNSHolding(s) in Company
23rd Mar 20173:26 pmRNSHolding(s) in Company
23rd Mar 20173:25 pmRNSHolding(s) in Company
17th Mar 201712:10 pmRNSPlacing to raise £3 million
8th Feb 20177:00 amRNSChange of Adviser
23rd Dec 201611:45 amRNSResult of AGM
7th Dec 20167:00 amRNSNew Portfolio Company - Tarsis Technology Limited
28th Nov 20167:00 amRNSPosting of Annual Report and Notice of AGM
21st Nov 20167:00 amRNSAudited final results for year ended 30 June 2016
4th Nov 201611:00 amRNSALUSID Wins Prestigious IChemE Award
14th Sep 201611:50 amRNSAgreement with FCT, Universidade NOVA de Lisboa
5th Sep 20167:00 amRNSNandi Proteins Participant in £1m Funding Award
27th Apr 20167:00 amRNSex scientia Limited - Partnership with Evotec AG
11th Apr 20163:31 pmRNSHolding(s) in Company
7th Apr 20167:05 amRNSHolding(s) in Company
7th Apr 20167:00 amRNSGrant of Options
31st Mar 20168:30 amRNSHolding(s) in Company
30th Mar 20169:00 amRNSHolding(s) in Company
24th Mar 20167:00 amRNSEquity Placing raising £1.0M & Total Voting Rights
9th Mar 20167:00 amRNSHalf-year results for the 6 months to 31 Dec 2015
7th Mar 20167:00 amRNSNandi Proteins Ltd: Further Successful Fundraising
8th Feb 20167:00 amRNSAgreement with first Portuguese University
21st Dec 201512:16 pmRNSResult of AGM
7th Dec 20157:00 amRNSAlusid wins prestigious Product of the Year award
1st Dec 20157:00 amRNSHolding(s) in Company
30th Nov 20154:20 pmRNSHolding(s) in Company
26th Nov 20157:00 amRNSPosting of Annual Report and Notice of AGM
19th Nov 20157:00 amRNSPreliminary results for year ended 30 June 2015
27th Oct 20157:00 amRNSPortfolio Company Fundraising - PulsiV Solar Ltd
14th Sep 20157:00 amRNSHolding(s) in Company
14th Sep 20157:00 amRNSHolding(s) in Company
24th Jul 20152:18 pmRNSHolding(s) in Company
10th Jul 20158:30 amRNSHolding(s) in Company
14th Apr 20157:00 amRNSHolding(s) in Company
10th Apr 20157:00 amRNSPlacing of new shares
31st Mar 20157:00 amRNSHalf Yearly Report
25th Mar 201510:52 amRNSPortfolio company, Alusid - First Fundraising
11th Mar 20157:00 amRNSKey development at portfolio company PulsiV Solar
10th Mar 20157:03 amRNSHolding(s) in Company
9th Mar 20157:00 amRNSNew advisory client, Vertequip
2nd Mar 20157:00 amRNSNew portfolio company
9th Feb 20157:00 amRNSScottish Enterprise Awards
5th Feb 20157:00 amRNSKey developments at portfolio company Alusid
2nd Feb 20157:00 amRNSHolding(s) in Company
7th Jan 20157:00 amRNSPortfolio company Nandi Proteins featured on BBC
29th Dec 201411:44 amRNSResult of AGM
4th Dec 20147:00 amRNSPosting of Annual Report & Notice of AGM
1st Dec 20147:00 amRNSFinal Results
26th Nov 20147:00 amRNSNew spin-out company
17th Nov 20147:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.